Table 5 Performance of serum lipids for predicting SAP.

From: Serum apolipoprotein B-to-apolipoprotein A1 ratio is independently associated with disease severity in patients with acute pancreatitis

Variable

AUC (95% CI)

P value

Cut-off

Sensitivity

Specificity

PLR

NLR

TC, mmol/L

0.553 (0.502–0.605)

0.160

4.05

43.08

63.55

1.18

0.90

TG, mmol/L

0.635 (0.584–0.684)

0.002

3.97

46.15

86.13

3.33

0.97

HDL-C, mmol/L

0.706 (0.657–0.752)

<0.001

1.23

76.92

54.37

1.69

0.42

LDL-C, mmol/L

0.531 (0.479–0.583)

0.457

3.10

33.85

41.52

1.33

0.89

ApoA1, g/L

0.692 (0.642–0.738)

<0.001

1.03

80.00

58.39

1.92

0.34

ApoB, g/L

0.653 (0.602–0.701)

<0.001

0.91

64.62

59.03

1.58

0.60

ApoB/A1 ratio

0.812 (0.769–0.851)

<0.001

0.88

83.08

69.03

2.68

0.25

  1. SAP, severe acute pancreatitis; AUC, area under curve; PLR, positive likelihood ratio; NLR, negative likelihood ratio; TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; ApoA1, apolipoprotein A1; ApoB, apolipoprotein B; ApoB/A1 ratio, apolipoprotein B-to-apolipoprotein A1 ratio.